Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Last trade$14.10
Day change-$0.395 (-2.73%)
Day range$14.05 – $14.49
Volume321,220
Market cap$899M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$898.93M
Price / earnings
64.05×
Price / book
3.29×
Price / sales
2.7×
EV / sales
1.97×
EV / EBITDA
41.03×
Profitability
Earnings per share
$0.23
Return on assets
4.03%
Return on equity
5.14%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
4.18×
Quick ratio
4.11×
Cash ratio
3.23×
Cash flow
Price / cash flow
31.33×
Price / free cash flow
31.93×
Free cash flow
$28.15M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for OMDA, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Revenue
$91.31M
$87.84M
$78.05M
$75.85M
$68.03M
$61.37M
Cost of revenue
$22.02M
$24.05M
$29.36M
$22.18M
$22.96M
$21.07M
Gross profit
$69.28M
$63.79M
$48.69M
$53.66M
$45.07M
$40.31M
Selling, general and administrative
$49.19M
$45.61M
$40.78M
$38.83M
$37.28M
$34.63M
Research and development
$15.27M
$14.63M
$12.7M
$11.55M
$10.3M
$10.02M
Total operating expenses
$64.46M
$60.24M
$53.47M
$50.38M
$47.58M
$44.65M
Operating income
$4.82M
$3.55M
-$4.78M
$3.28M
-$2.51M
-$4.34M
Interest expense
-$262K
-$14K
-$18K
-$13K
-$353K
-$1.09M
Income before taxes
$6.55M
$5.29M
-$2.97M
$5.16M
-$3.18M
-$5.31M
Income taxes
$0
$0
$0
$0
$0
$0
Net income
$6.55M
$5.29M
-$2.97M
$5.16M
-$3.18M
-$5.31M
Net income attributable to common shareholders
$6.55M
$5.29M
-$2.97M
$5.16M
-$3.18M
-$5.31M
EBITDA
$9.4M
$5.13M
-$3.27M
$4.73M
$1.31M
-$2.99M
Basic earnings per share
$0.11
$0.09
-$0.05
$0.09
-$0.06
-$0.24
Diluted earnings per share
$0.10
$0.08
-$0.05
$0.09
-$0.06
-$0.24
Recent news
Company coverage with links to the original publishers.
Omada Health reported strong Q3 2026 results with 34% year-over-year revenue growth to $91 million and raised full-year guidance. The company achieved record member retention of 2.5 years average tenure and reduced care delivery costs to an all-time low of $81 per member through AI automation. Omada's flexible GLP-1 product strategy positions it to benefit regardless of employer coverage decisions, while its $243 million cash position with no debt provides financial strength for expansion.
Omada Health reported Q3 2026 revenue of $91.31 million, up 34.2% year-over-year, beating the consensus estimate of $85.75 million by 6.48%. EPS came in at $0.17, significantly exceeding the $0.09 estimate by 88.89%. However, total members declined to 1.1 million from the estimated 1.12 million. The stock has a Zacks Rank #3 (Hold) rating and has underperformed the broader market, down 7% over the past month.
Omada Health (OMDA) reported Q3 2026 earnings of $0.17 per share, beating consensus estimates of $0.09 by 88.89%, with revenues of $91.31 million exceeding expectations by 6.48%. The company has outperformed market estimates four consecutive quarters. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. Peer company LifeMD is expected to report a quarterly loss of $0.14 per share with declining revenues.
The New York Academy of Medicine announced two new Board of Trustees members: Ann Marie McDonald, senior vice president and chief nursing executive at Hospital for Special Surgery, and Thomas Tsang, chief medical officer at Omada Health. Both leaders bring extensive expertise in healthcare quality, clinical operations, and technology-enabled care delivery.
Omada Health announced that senior management will participate in Canaccord Genuity's 46th annual Growth Conference in Boston on August 11, 2026, with a fireside chat. The company provides virtual healthcare services for chronic conditions and has served over two million members across 2,000+ employers and health plans.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.